Health product recall

JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules

Brand(s)
Last updated

Summary

Product
JAMP-Pregabalin
Issue
Health products - Product safety
What to do

Check your medication bottle or package. If your prescription is for 50 mg capsules and the bottle contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately. If you are unable to return your capsules to the pharmacy right away, talk to your pharmacist or doctor for further guidance. If you are experiencing symptoms of an overdose (described below), seek immediate medical attention. Do not stop taking your pregabalin medication.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

JAMP

JAMP-Pregabalin

DIN 02435985

Capsules

Pregabalin 50mg

2305012747

Issue

Affected lot (JAMP-Pregabalin 50mg) may contain capsule(s) of JAMP-Pregabalin 150mg.

What you should do

  • Check your medication bottle to ensure it only contains 50 mg capsules.
    • The 50 mg capsule is white with “PG” and “50” printed on it in black ink.
    • The 150 mg capsule is white with “PG” and “150” printed on it in black ink.
  • If it contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately. Your pharmacist will check the capsules and provide you with a replacement, if needed.
  • If you are unable to return your capsules to the pharmacy right away, talk to your pharmacist or doctor for further guidance.
  • Seek immediate medical attention if you are experiencing symptoms of an overdose (e.g., confusion, agitation, restlessness and seizures).
  • Do not stop taking pregabalin without first speaking to your doctor, as stopping abruptly may result in withdrawal symptoms.
  • If you have questions about this recall, contact JAMP Pharma Corp. by calling 1-866-399-9091, extension 501, or by emailing custjamp@jamppharma.com.
  • Report any health product-related side effects or complaints to Health Canada.

Additional information

Previous recalls or alerts
Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

 

JAMP Pharma Corporation

1310 Rue Nobel,

Boucherville, QC,

J4B 5H3

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-77402

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe